	Efficacy and safety of treatments in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor progression: a network meta-analysis and scoping review. BMC Cancer Zhang L, Sun F, Wang X, Zhao W, Jia Y, Wang H, Han Y, Tong Z. PMID: 41654790 [PubMed - as supplied by publisher]
	Cardioprotective effects of dapagliflozin against doxorubicin-induced cardiotoxicity in breast cancer patients with type 2 diabetes: a prospective study. BMC Cancer Ozturk HA, Koc M, Okyay RA, Ozturk DD, Gulumsek E, Buyuksimsek M, Turker M, Cetin AE, Arici FN, Sumbul HE. PMID: 41654775 [PubMed - as supplied by publisher]
	Resistance Mechanisms and Post-Trastuzumab Deruxtecan (T-DXd) Strategies in HER2+ and HER2-Low Breast Cancer: From Biology to Clinical Practice. Crit Rev Oncol Hematol Wen X, Wang W, Song J, Chen M, Xue W, Lin D, Li X, Zhang W, Shen J, Zeng D. PMID: 41654098 [PubMed - as supplied by publisher]
	Hallmarks of cancer in canine mammary tumors: Insights into a potential model for human triple-negative breast cancer. Crit Rev Oncol Hematol Ferreira T, Dias F, Gama A, Mano JF, Oliveira PA, Medeiros R. PMID: 41654097 [PubMed - as supplied by publisher]
	Early diagnosis of synchronous bilateral breast cancer using bilateral breast-selective prone-position [18F]FDG PET/MRI. Rev Esp Med Nucl Imagen Mol (Engl Ed) Garcia JR, Mont LL, Compte A, Pinilla L, Valls E, Riera E. PMID: 41653979 [PubMed - as supplied by publisher]
	Breast cancer genetics and risk assessment 101: What women's health care providers need to know. Maturitas Ruddy BE, Persons PA, Dacek ER. PMID: 41653705 [PubMed - as supplied by publisher]
	Incidence and impact on survival outcomes of postoperative radiological evidence of residual disease in women with advanced stage ovarian cancer undergoing debulking surgery: a meta-analysis. Eur J Surg Oncol Pergialiotis V, Thomakos N, Fanaki M, Lygizos V, Antonakis P, Bramis K, Alexakis N, Haidopoulos D. PMID: 41653656 [PubMed - as supplied by publisher]
	Breast Cancer Adjuvant Radiotherapy Without Tattoos: Comparison Between Surface Imaging and Four-point Localisation. Clin Oncol (R Coll Radiol) Lenci C, De Felice F, Tomaciello M, Caiazzo R, Arcieri S, Fantoni M, Montalto G, Magnante AL, Minniti G. PMID: 41653509 [PubMed - as supplied by publisher]
	Integrating antibody-drug conjugates into the management of early breast cancer. Cancer Treat Rev Alda MI, Grinda T, Pistilli B. PMID: 41653497 [PubMed - as supplied by publisher]
	[Nutraceuticals in the clinical management of women with breast cancer; a narrative review]. Semergen Luis Neyro JL, García Ortiz JP, Espitia de la Hoz FJ, Palacios S. PMID: 41653484 [PubMed - as supplied by publisher]
	Ultrasensitive next-generation sequencing-based detection of circulating human papillomavirus DNA for cervical cancer recurrence monitoring. Cancer Bønløkke S, Stougaard M, Sorensen BS, Parner E, Nyvang GB, Lindegaard JC, Blaakær J, Bertelsen J, Fuglsang K, Steiniche T. PMID: 41653072 [PubMed - indexed for MEDLINE]
	Assessment of risk factors of breast cancer among women in Dodoma, Tanzania: a community-based cross-sectional study. Libyan J Med Yahaya JJ, Joho AA. PMID: 41653056 [PubMed - indexed for MEDLINE]
	Clinicopathological factors associated with sentinel lymph node positivity in breast cancer using indocyanine green: a retrospective study in Peru. World J Surg Oncol Mendoza De Lama GW, Muñoz Quispe NE, Aguilar Cosme JM, Mendoza S, Hidalgo Ramos RE, Díaz-Llontop D, Castillo Laborio RE, Trejo Mena JM, Bedoya Ismodes EO, Taxa L. PMID: 41652639 [PubMed - as supplied by publisher]
	A comprehensive review of the emerging role of NRF3 in ovarian cancer tumorigenesis and progression. J Ovarian Res Hosseinzadeh M, Karimi A, Rashid M, Sadegi MR. PMID: 41652483 [PubMed - as supplied by publisher]
	Increased risk of fracture among breast cancer patients: a nationwide retrospective cohort study. J Cancer Surviv Cho H, Kim B, Han K, Kim S, Cho IY, Shin DW. PMID: 41652295 [PubMed - as supplied by publisher]
	A randomized clinical trial assessing the efficacy of vitamin B prophylaxis in attenuating paclitaxel-induced neuropathy and the imperative use of gabapentin in diabetic ovarian cancer patients. Med Oncol Haggagy M, Raslan F, Said NE, Ghaly S, Nassar H. PMID: 41652105 [PubMed - indexed for MEDLINE]
	Colonic metastasis from breast carcinoma: A case report and systematic review of a rare clinical scenario. Int J Colorectal Dis Matteucci M, Barone G, Zampino L, Codecà C, Dinuzzi VP, Battista A, Rivolta U, Yen M, Galliano M, Bertoglio CL. PMID: 41652066 [PubMed - indexed for MEDLINE]
	Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial. Commun Med (Lond) Landon BV, Boland JL, Wahner Hendrickson AE, Armstrong DK, Winterhoff B, Wehr J, Annapragada AV, Cherry C, Balan A, Kaleka G, Velculescu VE, Baylin SB, Zahnow CA, Slamon DJ, Konecny GE, Anagnostou V, Glaspy JA. PMID: 41652014 [PubMed - as supplied by publisher]
	Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial. Nat Commun Zhang P, Sun T, Wang Y, Li W, Tong Z, Phadke S, Feinstein T, Ma W, Guo P, Zhang M, Yue Y, Xu B. PMID: 41651834 [PubMed - as supplied by publisher]
	Why Does EGFR-Targeted Therapy Continue to Fail in Breast Cancer? From Mechanistic Deciphering to Novel Intervention Strategies. Crit Rev Oncol Hematol An X, Xie J, Wang W, Long T, Liang Q, Hou J. PMID: 41651315 [PubMed - as supplied by publisher]

Articles 1 - 20 / 324080

Page 1 of 16204



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy